Skimune®Pharm is a pre-clinical/clinical service tool. It is designed to predict first in-man adverse immune or allergic responses to new therapeutics.Find out more
Anne’s research at Newcastle University led to the founding of Alcyomics in 2007. Due to her expertise in immunobiology she has developed human skin based in vitro assays for predicting clinical responses prior to clinical trial.
Shaheda’s expertise includes cell and molecular biology and human skin explant assay technology.
Asif’s expertise includes cell biology, dermatology, and in vitro 3D assay technology.